The final phase of testing for the HIV drug “Lenacapavir” has demonstrated 99% effectiveness, according to Emory Univers…

The final phase of testing for the HIV drug “Lenacapavir” has demonstrated 99% effectiveness, according to Emory University. The drug was developed by researchers at Gilead Sciences.

Mass production and application of the medication are scheduled to begin in 2025. The main challenge remains its cost: a one-year treatment course is priced at $40,000. @science